Retrospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 645-653
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.645
Table 3 Incidence of adverse reactions in the two groups of patients, n (%)

Phlebitis
Gastrointestinal reactions
Oral ulcers
Liver and kidney dysfunction
Control group (n = 30)3 (10.0)6 (20.0)4 (13.3)2 (6.7)
Observation group (n = 30)10 (33.3)15 (50.0)11 (36.7)8 (26.7)
t value4.81215.93414.35614.3201
P value0.02830.01490.03690.0377